※ 출처: ClinicalTrials.gov
총 197건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) Esophageal Squamous Cell Carcinoma (ESCC)|Siewert Type I Adenocarcinoma of the Esophagogastric Junction (EGJ)|Esophageal Adenocarcinoma (EAC) Biological: pembrolizumab|Drug: placebo|Drug: cisplatin|Drug: 5-FU|Radiation: radiotherapy|Drug: leucovorin|Drug: levoleucovorin|Drug: oxaliplatin Merck Sharp & Dohme Corp. Phase 3 2020-02-28
2 Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991) Metastatic Hormone-Sensitive Prostate Cancer Biological: Pembrolizumab|Drug: Enzalutamide|Procedure: Androgen Deprivation Therapy (ADT)|Other: Placebo Merck Sharp & Dohme Corp. Phase 3 2020-02-12
3 Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease) CD55-deficient Protein-losing Enteropathy|CHAPLE Drug: Pozelimab Regeneron Pharmaceuticals Phase 2|Phase 3 2020-01-27
4 A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation Carcinoma, Hepatocellular Drug: Atezolizumab|Drug: Bevacizumab Hoffmann-La Roche Phase 3 2019-12-31
5 A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer Prostate Cancer Biological: nivolumab|Drug: prednisone|Drug: docetaxel Bristol-Myers Squibb Phase 3 2019-12-06
6 Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients Alzheimer Disease|Parkinson Disease Drug: Metabolic Cofactor Supplementation|Drug: Sorbitol Istanbul Medipol University Hospital|ScandiBio Therapeutics AB|Alanya Alaaddin Keykubat University|Sahlgrenska University Hospital, Sweden|KTH Royal Institute of Technology Phase 2 2019-12-01
7 A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis Spondyloarthritis Drug: Upadacitinib|Drug: Placebo AbbVie Phase 3 2019-11-26
8 Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007) Solid Tumors Drug: Olaparib|Biological: Pembrolizumab Merck Sharp & Dohme Corp. Phase 2 2019-11-18
9 Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) Type 2 Diabetes Mellitus Drug: Ertugliflozin 5 mg|Drug: Ertugliflozin 15 mg|Drug: Placebo|Biological: Insulin|Drug: Metformin Merck Sharp & Dohme Corp.|Pfizer Phase 3 2019-10-08
10 Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome Sjögren Syndrome Drug: CFZ533|Other: Placebo Novartis Pharmaceuticals|Novartis Phase 2 2019-10-01